Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04565054
Title Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC (ADAPTlate)
Acronym ADAPTlate
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors West German Study Group
Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.